Common use of Purchase Warrant Clause in Contracts

Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of [_____] (“Holder”), as registered owner of this Purchase Warrant, to Cannabics Pharmaceuticals Inc., a Nevada corporation (the “Company”), Holder is entitled, at any time or from time to time from March 26, 2019 (the “Commencement Date”), and at or before 5:00 p.m., Eastern time, March 26, 2022 (the ”Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [____] shares of common stock of the Company, par value $0.0001 per share (the “Shares”), subject to adjustment as provided in Section 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $0.9375 per Share; provided, however, that upon the occurrence of any of the events specified in Section 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term “Exercise Price” shall mean the initial exercise price or the adjusted exercise price, depending on the context.

Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of [_________________] (“Holder”), as registered owner of this Purchase Warrant, to Cannabics Pharmaceuticals Superconductor Technologies Inc., a Nevada Delaware corporation (the “Company”), Holder is entitled, at any time or from time to time from March November 26, 2019 2013 (the “Commencement Date”), and at or before 5:00 p.m., Eastern time, March 26November 25, 2022 2016 (the ”“Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [____] 100,000 shares of common stock of the Company, par value $0.0001 0.001 per share (the “Shares”), subject to adjustment as provided in Section 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $0.9375 0.375 per ShareShare (125% of the price of the Shares sold in the Offering); provided, however, that upon the occurrence of any of the events specified in Section 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term “Exercise Price” shall mean the initial exercise price or the adjusted exercise price, depending on the context.

Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of [_____] P.X. Xxxxx (“Holder”), as registered owner of this Purchase Warrant, to Cannabics Pharmaceuticals Edison Nation, Inc., a Nevada corporation (the “Company”), Holder is entitled, at any time or from time to time from March 26, 2019 the date hereof (the “Commencement Date”), and at or before 5:00 p.m., Eastern time, March 26December 31, 2022 2020 (the ”“Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [____] 50,000 shares of common stock of the Company, par value $0.0001 0.001 per share (the “Shares”), subject to adjustment as provided in Section 6 5 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at a fixed amount of $0.9375 2.00 per Share; provided, however, that upon the occurrence of any of the events specified in Section 6 5 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term “Exercise Price” shall mean the initial exercise price or the adjusted exercise price, depending on the context.

Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of [_____] Brean Capital, LLC (“Holder”), as registered owner of this Purchase Warrant, to Cannabics Pharmaceuticals Inc.ClearSign Combustion Corporation, a Nevada Washington corporation (the “Company”), Holder is entitled, at any time or from time to time from March 265, 2019 2014 (the “Commencement Date”), and at or before 5:00 p.m., Eastern time, March 265, 2022 2019 (the ”Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [____] 20,313 shares of common stock of the Company, par value $0.0001 per share (the “Shares”), subject to adjustment as provided in Section 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this the Purchase Warrant. This Purchase Warrant is initially exercisable at $0.9375 10.00 per ShareShare (125% of the price of the Shares sold in the Offering); provided, however, that upon the occurrence of any of the events specified in Section 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term “Exercise Price” shall mean the initial exercise price or the adjusted exercise price, depending on the context.

Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of [_____] Xxxxxx Xxxxx Securities, Inc. (“Holder”), as registered owner of this Purchase Warrant, to Cannabics Pharmaceuticals Smart for Life, Inc., a Nevada Delaware corporation (the “Company”), Holder is entitled, at any time or from time to time from March 26, 2019 (the “Commencement Date”), and at or before 5:00 p.m., Eastern time, March 26December 8, 2022 2027 (the ”“Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [____] 8,000 shares of common stock of the Company, par value $0.0001 per share (the “Shares”), subject to adjustment as provided in Section 6 5 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $0.9375 0.35 per Share; provided, however, that upon the occurrence of any of the events specified in Section 6 5 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term “Exercise Price” shall mean the initial exercise price or the adjusted exercise price, depending on the context.

Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of [_____] Maxim Group LLC or its assigns (“Holder”), as registered owner of this Purchase Warrant, to Cannabics Pharmaceuticals Advaxis, Inc., a Nevada Delaware corporation (the “Company”), Holder is entitled, at any time or from time to time from March 26September 17, 2019 2013 (the “Commencement Date”), and at or before 5:00 p.m., Eastern time, March 26September 17, 2022 2015 (the ”Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [____] 30,154 shares of common stock of the Company, par value $0.0001 0.001 per share (the “Shares”), subject to adjustment as provided in Section 6 5 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $0.9375 4.90 per Share; provided, however, that upon the occurrence of any of the events specified in Section 6 5 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term “Exercise Price” shall mean the initial exercise price or the adjusted exercise price, depending on the context.

Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of [______] (“Holder”), as registered owner of this Purchase Warrant, to Cannabics Pharmaceuticals ICZOOM Group Inc., a Nevada Cayman Island corporation (the “Company”), Holder is entitled, at any time or from time to time from March 26[●], 2019 2024 (the “Commencement Date”), and at or before 5:00 p.m., Eastern time, March 26, 2022 [●] (the ”Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [____●] Class A ordinary shares of common stock of the Company, par value $0.0001 per share Company (the “Shares”), subject to adjustment as provided in Section 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $0.9375 [●] per Share; provided, however, that upon the occurrence of any of the events specified in Section 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term “Exercise Price” shall mean the initial exercise price or the adjusted exercise price, depending on the context.

Purchase Warrant. THIS CERTIFIES THAT, in exchange for consideration of funds duly paid by received from or on behalf of [_____] Start Media, LLC (“Holder”), as registered owner of this Purchase Warrant, to Cannabics Pharmaceuticals Inc., a Nevada corporation by Digital Cinema Destinations Corp. (the “Company”), the receipt and sufficiency of which is hereby acknowledged, Holder is entitled, at any time or from time to time from March 26, 2019 (after the “Commencement Date”)date hereof, and at or before 5:00 p.m.5:00p.m., Eastern timeTime on December 10, March 26, 2022 2017 (the ”“Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [____] 500,000 shares of Class A common stock of the Company, par value $0.0001 0.01 per share (the “Shares”), subject to adjustment as provided in Section 6 5 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this the Purchase Warrant. This Purchase Warrant is initially exercisable at $0.9375 6.10 per Share; provided, however, that upon the occurrence of any of the events specified in Section 6 5 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term “Exercise Price” shall mean the initial exercise price or the adjusted exercise price, depending on the context.

Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds $100 duly paid by or on behalf of [_____] I-Bankers Securities, Inc. (“"Holder”"), as registered owner of this Purchase Warrant, to Cannabics Pharmaceuticals Inc.SGOCO Group, a Nevada corporation Ltd. (the “"Company”"), Holder is entitled, at any time or from time to time from March 26June 12, 2019 2012 (the “"Commencement Date”"), and at or before 5:00 p.m., Eastern timeTime, March 26until December 20, 2022 2015 (the ”"Expiration Date”"), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [____] 66,667 shares of common ordinary stock of the Company, par value $0.0001 .001 per share (the “"Shares”), ") subject to adjustment as provided in Section 6 5 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this the Purchase Warrant. This Purchase Warrant is initially exercisable at $0.9375 6.00 per ShareShare (120%) of the price of the Shares sold in the Offering) so purchased; provided, however, that upon the occurrence of any of the events specified in Section 6 5 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term “"Exercise Price” " shall mean the initial exercise price or the adjusted exercise price, depending on the context. This Purchase Warrants and all of the Shares have been registered by the Company with the Securities and Exchange Commission pursuant to Form F-1 (Registration No. 333-170674), effective on December 20, 2010.

Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of [_____·] (“Holder”), as registered owner of this Purchase Warrant, to Cannabics Pharmaceuticals Advaxis, Inc., a Nevada Delaware corporation (the “Company”), Holder is entitled, at any time or from time to time from March 26[·], 2019 2014 (the “Commencement Date”), and at or before 5:00 p.m., Eastern time, March 26[·], 2022 2018 (the ”“Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [____·] shares of common stock of the CompanyCompany [equal to 3% of the Shares sold in the Offering], par value $0.0001 0.001 per share (the “Shares”), subject to adjustment as provided in Section 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this the Purchase Warrant. This Purchase Warrant is initially exercisable at $0.9375 [·] per ShareShare (125% of the price of the Shares sold in the Offering); provided, however, that upon the occurrence of any of the events specified in Section 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term “Exercise Price” shall mean the initial exercise price or the adjusted exercise price, depending on the context.

Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of [_____] Aegis Capital Corp. (“Holder”), as registered owner of this Purchase Warrant, to Cannabics Pharmaceuticals Ceres, Inc., a Nevada Delaware corporation (the “Company”), Holder is entitled, at any time or from time to time from March 264, 2019 (the 2015(the “Commencement Date”), and at or before 5:00 p.m., Eastern time, March 264, 2022 2019 (the ”Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [____] 480,000 shares of common stock of the Company, par value $0.0001 0.01 per share (the “Shares”), subject to adjustment as provided in Section 6 5 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $0.9375 1.50 per Share; provided, however, that upon the occurrence of any of the events specified in Section 6 5 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term “Exercise Price” shall mean the initial exercise price or the adjusted exercise price, depending on the context.

Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by for value received, [•] or on behalf of [_____] its assigns (“Holder”), as registered owner of this Purchase Warrant, to Cannabics Pharmaceuticals Inc., a Nevada corporation (the “Company”), Holder is entitled, at any time or from time to time from March 26[•], 2019 2016 (the “Commencement Date”), and until at or before 5:00 p.m., Eastern time, March 26[•], 2022 2020 (the ”“Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [____•] shares of common stock of Naked Brand Group, Inc., a Nevada corporation (the “Company”), par value $0.0001 0.001 per share (the “Shares”), subject to adjustment as provided in Section 6 5 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $0.9375 4.80 per Share; provided, however, that upon the occurrence of any of the events specified in Section 6 5 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term “Exercise Price” shall mean the initial exercise price or the adjusted exercise price, depending on the context. The term “Effective Date” shall mean December 17, 2015, the date on which the Registration Statement on Form S-1 (File No. 333-207110) of the Company (the “Registration Statement”) was declared effective by the U.S. Securities and Exchange Commission (the “Commission”).

Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of [_____] Boustead Securities, LLC (“Holder”), as registered owner of this Purchase Warrant, to Cannabics Pharmaceuticals Mangoceuticals, Inc., a Nevada Texas corporation (the “Company”), Holder is entitled, at any time or from time to time from March 26, 2019 (beginning the “Commencement Effective Date”), and at or before 5:00 p.m., Eastern time, March 26December 14, 2022 2028 (the ”“Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [____] 280,000 shares (the “Shares”) of common stock of the Company, par value $0.0001 per share (the “SharesCommon Stock”), subject to adjustment as provided in Section 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $0.9375 0.375 per Share; provided, however, that upon the occurrence of any of the events specified in Section 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term “Exercise Price” shall mean the initial exercise price or the adjusted exercise price, depending on the context.

Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of [_____●] (“Holder”), as registered owner of this Purchase Warrant, to Cannabics Pharmaceuticals Inc.Kairos Pharma, Ltd., a Nevada Delaware corporation (the “Company”), Holder is entitled, at any time or from time to time from March 26, 2019 (beginning the “Commencement Effective Date”), and at or before 5:00 p.m., Eastern time, March 26[●], 2022 202[●]2 (the ”“Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [____●] shares (the “Shares”) of common stock of the Company, par value $0.0001 0.001 per share (the “SharesCommon Stock”), subject to adjustment as provided in Section 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $0.9375 [●]3 per Share; provided, however, that upon the occurrence of any of the events specified in Section 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term “Exercise Price” shall mean the initial exercise price or the adjusted exercise price, depending on the context.

Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of [_____] Equity Trust Company Custodian, FBO: Rxxxxxxx Xxxxx Rxxxx XXX (“Holder”), as registered owner of this Purchase Warrant, to Cannabics Pharmaceuticals Edison Nation, Inc., a Nevada corporation (the “Company”), Holder is entitled, at any time or from time to time from March 26, 2019 the date hereof (the “Commencement Date”), and at or before 5:00 p.m., Eastern time, March 26December 31, 2022 2020 (the ”“Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [____] 125,000 shares of common stock of the Company, par value $0.0001 0.001 per share (the “Shares”), subject to adjustment as provided in Section 6 5 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at a fixed amount of $0.9375 2.00 per Share; provided, however, that upon the occurrence of any of the events specified in Section 6 5 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term “Exercise Price” shall mean the initial exercise price or the adjusted exercise price, depending on the context.

Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of [_____·] (“Holder”), as registered owner of this Purchase Warrant, to Cannabics Pharmaceuticals Axxxx Biosciences, Inc., a Nevada New Jersey corporation (the “Company”), Holder is entitled, at any time or from time to time from March 26[_________], 2019 2014 (the “Commencement Date”), and at or before 5:00 p.m., Eastern time, March 26[___________], 2022 2018 (the ”“Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [____·] shares of common stock of the CompanyCompany [equal to 3% of the Shares sold in the Offering], par value $0.0001 0.001 per share (the “Shares”), subject to adjustment as provided in Section 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this the Purchase Warrant. This Purchase Warrant is initially exercisable at $0.9375 [___] per ShareShare (125% of the price of the Shares sold in the Offering); provided, however, that upon the occurrence of any of the events specified in Section 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term “Exercise Price” shall mean the initial exercise price or the adjusted exercise price, depending on the context.

Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid services rendered by or on behalf of [_____] Aegis Capital Corp. (“Holder”), as registered owner of this Purchase Warrant, to Cannabics Pharmaceuticals The OLB Group, Inc., a Nevada Delaware corporation (the “Company”), Holder is entitled, at any time or from time to time from March 26August 6, 2019 2021 (the “Commencement Date”), and at or before 5:00 p.m., Eastern time, March 26August 6, 2022 2025 (the ”Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [____] thirty five thousand (35,000) shares of common stock of the Company, par value $0.0001 per share (the “Shares”), subject to adjustment as provided in Section 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $0.9375 11.25 per Share; provided, however, that upon the occurrence of any of the events specified in Section 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share Shares and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term “Exercise Price” shall mean the initial exercise price or the adjusted exercise price, depending on the context.

Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of [_____] Boustead Securities, LLC (“Holder”), as registered owner of this Purchase Warrant, to Cannabics Pharmaceuticals Mangoceuticals, Inc., a Nevada Texas corporation (the “Company”), Holder is entitled, at any time or from time to time from March 26, 2019 (beginning the “Commencement Effective Date”), and at or before 5:00 p.m., Eastern time, March 26December 14, 2022 2028 (the ”“Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [____] 42,000 shares (the “Shares”) of common stock of the Company, par value $0.0001 per share (the “SharesCommon Stock”), subject to adjustment as provided in Section 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $0.9375 0.375 per Share; provided, however, that upon the occurrence of any of the events specified in Section 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term “Exercise Price” shall mean the initial exercise price or the adjusted exercise price, depending on the context.

Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of [_____] Aegis Capital Corp. (“Holder”), as registered owner of this Purchase Warrant, to Cannabics Pharmaceuticals NanoFlex Inc., a Nevada Florida corporation (the “Company”), Holder is entitled, at any time or from time to time from March 26_______, 2019 20__ (the “Commencement Date”), and at or before 5:00 p.m.5:00p.m., Eastern time, March 26________, 2022 20__ (the ”Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [____] __ shares of common stock of the Company, par value $0.0001 per share (the “Shares”), subject to adjustment as provided in Section 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $0.9375 ______ per Share; provided, however, that upon the occurrence of any of the events specified in Section 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term “Exercise Price” shall mean the initial exercise price or the adjusted exercise price, depending on the context.

Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of [_____] Xxxxx Xxxxxxx (“Holder”), as registered owner of this Purchase Warrant, to Cannabics Pharmaceuticals Smart for Life, Inc., a Nevada Delaware corporation (the “Company”), Holder is entitled, at any time or from time to time from March 26, 2019 (the “Commencement Date”), and at or before 5:00 p.m., Eastern time, March 26December 8, 2022 2027 (the ”“Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [____] 18,286 shares of common stock of the Company, par value $0.0001 per share (the “Shares”), subject to adjustment as provided in Section 6 5 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $0.9375 0.35 per Share; provided, however, that upon the occurrence of any of the events specified in Section 6 5 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term “Exercise Price” shall mean the initial exercise price or the adjusted exercise price, depending on the context.

Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of [_____] Xxxxx X. Xxxxx (“Holder”), as registered owner of this Purchase WarrantWarrant of Stran & Company, to Cannabics Pharmaceuticals Inc., a Nevada corporation (the “Company”), Holder is entitled, at any time or from time to time from March 26May 12, 2019 2022 (the “Commencement Date”), and at or before 5:00 p.m., Eastern time, March 26November 12, 2022 2026 (the ”Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [____] 62,287 shares of common stock of the Company, par value $0.0001 per share (the “Shares”), subject to adjustment as provided in Section 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $0.9375 5.1875 per Share; provided, however, that upon the occurrence of any of the events specified in Section 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term “Exercise Price” shall mean the initial exercise price or the adjusted exercise price, depending on the context. The term “Effective Date” shall mean November 8, 2021, the date on which the Registration Statement on Form S-1 (File No. 333-260109) of the Company was declared effective by the Securities and Exchange Commission.

Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of [_____] Xxxxxx X. Xxxxx (“Holder”), as registered owner of this Purchase WarrantWarrant of Stran & Company, to Cannabics Pharmaceuticals Inc., a Nevada corporation (the “Company”), Holder is entitled, at any time or from time to time from March 26May 12, 2019 2022 (the “Commencement Date”), and at or before 5:00 p.m., Eastern time, March 26November 12, 2022 2026 (the ”Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [____] 62,287 shares of common stock of the Company, par value $0.0001 per share (the “Shares”), subject to adjustment as provided in Section 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $0.9375 5.1875 per Share; provided, however, that upon the occurrence of any of the events specified in Section 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term “Exercise Price” shall mean the initial exercise price or the adjusted exercise price, depending on the context. The term “Effective Date” shall mean November 8, 2021, the date on which the Registration Statement on Form S-1 (File No. 333-260109) of the Company was declared effective by the Securities and Exchange Commission.

Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid for value received by or on behalf of [_____Titan Pharmaceuticals, Inc., a Delaware corporation (the “Company”), [ ] (“Holder”), as registered owner of this Purchase Warrant, to Cannabics Pharmaceuticals Inc., a Nevada corporation (the “Company”), Holder is entitled, at any time or from time to time from March 26September 20, 2019 (the “Commencement Date”), and at or before 5:00 p.m., Eastern time, March 26September 20, 2022 2023 (the ”Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [____] shares of common stock of the Company, par value $0.0001 0.001 per share (the “Shares”), subject to adjustment as provided in Section 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $0.9375 0.28 per Share; provided, however, that upon the occurrence of any of the events specified in Section 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term “Exercise Price” shall mean the initial exercise price or the adjusted exercise price, depending on the context.

Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of [_____] Spartan Capital Securities, LLC (“Holder”), as registered owner of this Purchase Warrant, to Cannabics Pharmaceuticals Inc.Warrant of Trio Petroleum Corp., a Nevada Delaware corporation (the “Company”), Holder is entitled, at any time or from time to time from March 26April 20, 2019 2023 (the “Commencement Date”), and at or before 5:00 p.m., Eastern time, March 26April 17, 2022 2028 (the ”“Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [____] 100,000 shares of common stock of the Company, par value $0.0001 per share (the “Shares”), subject to adjustment as provided in Section 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $0.9375 3.30 per Share; provided, however, that upon the occurrence of any of the events specified in Section 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term “Exercise Price” shall mean the initial exercise price or the adjusted exercise price, depending on the context. The term “Effective Date” shall mean April 17, 2023, the date on which the Registration Statement on Form S-1 (File No. 333-267380) of the Company was declared effective by the Securities and Exchange Commission.

Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of [_____] Boustead Securities, LLC (“Holder”), as registered owner of this Purchase Warrant, to Cannabics Pharmaceuticals Asset Entities Inc., a Nevada corporation (the “Company”), Holder is entitled, at any time or from time to time from March 26beginning February 7, 2019 2023 (the “Commencement Date”), and at or before 5:00 p.m., Eastern time, March 26February 2, 2022 2028 (the ”“Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [____] 105,000 shares (the “Shares”) of common stock Class B Common Stock of the Company, par value $0.0001 per share (the “SharesCommon Stock”), subject to adjustment as provided in Section 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $0.9375 6.25 per Share; provided, however, that upon the occurrence of any of the events specified in Section 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term “Exercise Price” shall mean the initial exercise price or the adjusted exercise price, depending on the context.

Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of [_____] Aegis Capital Corp. (“Holder”), as registered owner of this Purchase Warrant, to Cannabics Pharmaceuticals Alset EHome International Inc., a Nevada Delaware corporation (the “Company”), Holder is entitled, at any time or from time to time from March 26beginning July 30, 2019 2021 (the “Commencement Date”), and at or before 5:00 p.m., Eastern time, March 26July 30, 2022 2023 (the ”“Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [____] 452,830 shares of common stock of the Company, par value $0.0001 0.001 per share (the “Shares”), subject to adjustment as provided in Section 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $0.9375 2.65 per Share; provided, however, that upon the occurrence of any of the events specified in Section 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term “Exercise Price” shall mean the initial exercise price or the adjusted exercise price, depending on the context.

Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of [_____[ ] (“Holder”), as registered owner of this Purchase Warrant, to Cannabics Pharmaceuticals Data443 Risk Mitigation, Inc., a Nevada corporation (the “Company”), Holder is entitled, at any time or from time to time from March 26beginning [ ], 2019 2023 (the “Commencement Date”), and at or before 5:00 p.m., Eastern time, March 26[ ], 2022 2028 (the ”“Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [____[ ] shares of common stock of the Company, par value $0.0001 0.001 per share (the “Shares”), subject to adjustment as provided in Section 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $0.9375 [ ] per Share; provided, however, that upon the occurrence of any of the events specified in Section 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term “Exercise Price” shall mean the initial exercise price or the adjusted exercise price, depending on the context.

Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of [_____] (“Holder”), as registered owner of this Purchase Warrant, to Cannabics Pharmaceuticals Ceres, Inc., a Nevada Delaware corporation (the “Company”), Holder is entitled, at any time or from time to time from March 264, 2019 (the 2015(the “Commencement Date”), and at or before 5:00 p.m., Eastern time, March 264, 2022 2019 (the ”Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [____] 22,000 shares of common stock of the Company, par value $0.0001 0.01 per share (the “Shares”), subject to adjustment as provided in Section 6 5 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $0.9375 1.50 per Share; provided, however, that upon the occurrence of any of the events specified in Section 6 5 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term “Exercise Price” shall mean the initial exercise price or the adjusted exercise price, depending on the context.

Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of [_____] Benchmark Investments, LLC (“Holder”), as registered owner of this Purchase WarrantWarrant of Stran & Company, to Cannabics Pharmaceuticals Inc., a Nevada corporation (the “Company”), Holder is entitled, at any time or from time to time from March 26May 12, 2019 2022 (the “Commencement Date”), and at or before 5:00 p.m., Eastern time, March 26November 12, 2022 2026 (the ”Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [____] 10,101 shares of common stock of the Company, par value $0.0001 per share (the “Shares”), subject to adjustment as provided in Section 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $0.9375 5.1875 per Share; provided, however, that upon the occurrence of any of the events specified in Section 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term “Exercise Price” shall mean the initial exercise price or the adjusted exercise price, depending on the context. The term “Effective Date” shall mean November 8, 2021, the date on which the Registration Statement on Form S-1 (File No. 333-260109) of the Company was declared effective by the Securities and Exchange Commission.

Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of [_____[ ] (“Holder”), as registered owner of this Purchase Warrant, to Cannabics Pharmaceuticals AxurRx BioPharma, Inc., a Nevada Delaware corporation (the “Company”), Holder is entitled, at any time or from time to time from March 26April 3, 2019 2020 (the “Commencement Date”), and at or before 5:00 p.m., Eastern timetime April 3, March 26, 2022 2025 (the ”“Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [____●] shares of common stock of the Company, par value $0.0001 per share (the “Shares”), subject to adjustment as provided in Section 6 5 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $0.9375 2.55 per Share; provided, however, that upon the occurrence of any of the events specified in Section 6 5 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term This Warrant is being issued pursuant to the certain Selling Agent Agreement (the “Exercise Price” shall mean Selling Agent Agreement”), dated April 1, 2019, by and among the initial exercise price or Company and the adjusted exercise priceHolder, depending on providing for the context.public offering (the “Offering”) of shares of common stock, par value

Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of [_____·] (“Holder”), as registered owner of this Purchase Warrant, to Cannabics Pharmaceuticals Sxxxxx Scientific, Inc., a Nevada Delaware corporation (the “Company”), Holder is entitled, at any time or from time to time from March 26[·], 2019 20[14] (the “Commencement Date”), and at or before 5:00 p.m., Eastern time, March 26[·], 2022 20[18] (the ”“Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [____·] shares of common stock of the CompanyCompany [equal to 5% of the Shares sold in the Offering], par value $0.0001 0.001 per share (the “Shares”), subject to adjustment as provided in Section 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this the Purchase Warrant. This Purchase Warrant is initially exercisable at $0.9375 [·] per ShareShare (125% of the price of the Shares sold in the Offering); provided, however, that upon the occurrence of any of the events specified in Section 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term “Exercise Price” shall mean the initial exercise price or the adjusted exercise price, depending on the context.

Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of [_____] Xxxxxx X. Xxxxxx, Xx. (“Holder”), as registered owner of this Purchase Warrant, to Cannabics Pharmaceuticals Smart for Life, Inc., a Nevada Delaware corporation (the “Company”), Holder is entitled, at any time or from time to time from March 26, 2019 (the “Commencement Date”), and at or before 5:00 p.m., Eastern time, March 26December 8, 2022 2027 (the ”“Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [____] 88,000 shares of common stock of the Company, par value $0.0001 per share (the “Shares”), subject to adjustment as provided in Section 6 5 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $0.9375 0.35 per Share; provided, however, that upon the occurrence of any of the events specified in Section 6 5 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term “Exercise Price” shall mean the initial exercise price or the adjusted exercise price, depending on the context.

Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of [_____] ________ (“Holder”), as registered owner of this Purchase Warrant, to Cannabics Pharmaceuticals Ampio Pharmaceuticals, Inc., a Nevada Delaware corporation (the “Company”), Holder is entitled, at any time or from time to time from March 26July 12, 2019 2013 (the “Commencement Date”), and at or before 5:00 p.m., Eastern time, March 26July 12, 2022 2017 (the ”“Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [ ] [____3% of shares sold in offering excluding over-allotment] shares of common stock of the Company, par value $0.0001 per share (the “Shares”), subject to adjustment as provided in Section 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $0.9375 4.0625 per ShareShare (125% of the price of the Shares sold in the Offering); provided, however, that upon the occurrence of any of the events specified in Section 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term “Exercise Price” shall mean the initial exercise price or the adjusted exercise price, depending on the context.

Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of [_____] ____________ (“Holder”), as registered owner of this Purchase Warrant, to Cannabics Pharmaceuticals Metro One Telecommunications, Inc., a Nevada Delaware corporation (the “Company”), Holder is entitled, at any time or from time to time from March 26, 2019 ________________ (the “Commencement Date”), and at or before 5:00 p.m., Eastern time, March 26, 2022 _________________ (the ”Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [____] _________ shares of common stock of the Company, par value $0.0001 per share (the “Shares”), subject to adjustment as provided in Section 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $0.9375 0.15 per Share; provided, however, that upon the occurrence of any of the events specified in Section 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term “Exercise Price” shall mean the initial exercise price or the adjusted exercise price, depending on the context.

Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of [______] (“Holder”), as registered owner of this Purchase Warrant, to Cannabics Pharmaceuticals Aditxt, Inc., a Nevada Delaware corporation (the “Company”), Holder is entitled, at any time or from time to time from March 262, 2019 2022 (the “Commencement Date”), and at or before 5:00 p.m., Eastern time, March 26, 2022 August 26 2026 (the ”“Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [_____] shares of common stock of the Company, par value $0.0001 0.001 per share (the “Shares”), subject to adjustment as provided in Section 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $0.9375 [_____] per Share; provided, however, that upon the occurrence of any of the events specified in Section 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term “Exercise Price” shall mean the initial exercise price or the adjusted exercise price, depending on the context.

Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of [_____] Xxxxxx Xxxxx Securities, Inc. (“Holder”), as registered owner of this Purchase Warrant, to Cannabics Pharmaceuticals Smart for Life, Inc., a Nevada Delaware corporation (the “Company”), Holder is entitled, at any time or from time to time from March 26, 2019 (the “Commencement Date”), and at or before 5:00 p.m., Eastern time, March 26December 8, 2022 2027 (the ”“Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [____] 114,286 shares of common stock of the Company, par value $0.0001 per share (the “Shares”), subject to adjustment as provided in Section 6 5 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $0.9375 0.35 per Share; provided, however, that upon the occurrence of any of the events specified in Section 6 5 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term “Exercise Price” shall mean the initial exercise price or the adjusted exercise price, depending on the context.

Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of [______] (“Holder”), as registered owner of this Purchase Warrant, to Cannabics Pharmaceuticals SunCar Technology Group, Inc., a Nevada Cayman Island corporation (the “Company”), Holder is entitled, at any time or from time to time from March 26, 2019 [___] (the “Commencement Date”), and at or before 5:00 p.m., Eastern time, March 26, 2022 [___]2 (the ”“Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [____] ]3 Class A ordinary shares of common stock of the Company, par value $0.0001 per share Company (the “Shares”), subject to adjustment as provided in Section 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $0.9375 [___]4 per Share; provided, however, that upon the occurrence of any of the events specified in Section 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term “Exercise Price” shall mean the initial exercise price or the adjusted exercise price, depending on the context.